Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Plum Street
Suite # 600
New Brunswick, NJ 08901Phone+1 732-220-1600Fax+1 732-220-1603
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2006 - 2009
United Health Services HospitalsInternship, Transitional Year, 2005 - 2006
Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
CA State Medical License 2007 - Present
NJ State Medical License 2013 - 2025
MA State Medical License 2009 - 2017
CT State Medical License 2011 - 2015- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Reply.Alyssa C Bonnell, Dimosthenis Mantopoulos, Howard F Fine, Sumit P Shah, H Matthew Wheatley
Retina. 2021-09-01 - 30 citationsThe Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections.Samir N Patel, Peter H Tang, Philip Storey, Jeremy D. Wolfe, Jordana G. Fein
Ophthalmology. 2021-05-18 - 20 citationsIntravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial.Jeffrey S. Heier, David M. Brown, Sumit P. Shah, Namrata Saroj, Sabin Dang
JAMA Ophthalmology. 2021-05-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
